|
Post by mango on Apr 16, 2019 14:09:13 GMT -5
Maybe ask about the long-term safety study & what their plan is etc
|
|
|
Post by seanismorris on Apr 16, 2019 14:21:19 GMT -5
Why not ask Mike what realistic timelines for Brazil and India approvals are with target dates based on current efforts and study requirements. The vague response he gave after the Cipla denial was not a sufficient answer. He has stated that the revenue would not be significant, but I think any global approval would show real expansion opportunity and help SP. I would also ask for clairification on what he mean't when he said Canada is now a focus. Was he illuding to only cannabas with RLS only or Afrezza approval too? At last years ASM attending shareholders invited him to dinner the night before. He didn't make dinner but did stop by for a drink and spent an hour answering many questions we had taken down. I won't be going to New York unfortunately, but I suggest that those who are try to do the same. We posted many of the answers last year here on PB. All good questions... Mike’s answer will have a lot more words, but we can sum it up as ¯\_(ツ)_/¯
|
|
|
Post by mango on Apr 16, 2019 16:04:47 GMT -5
They said that they had other business in NYC that same week. What comes to mind ... walking distance from the hotel: Deerfield HQ, Leerink HQ, BTIG HQ! [ So, were they being mindful of their shareholders and the Company's wallet when planning this?
|
|
|
Post by awesomo on Apr 16, 2019 16:09:43 GMT -5
They said that they had other business in NYC that same week. What comes to mind ... walking distance from the hotel: Deerfield HQ, Leerink HQ, BTIG HQ! [ So, were they being mindful of their shareholders and the Company's wallet when planning this? Considering talking to these firms leads to financing (dilution, debt, etc), I’m going to go with a no.
|
|